Journal Title：Journal Of Child And Adolescent Psychopharmacology

Journal of Child and Adolescent Psychopharmacology (JCAP) is the premier peer-reviewed journal covering the clinical aspects of treating this patient population with psychotropic medications including side effects and interactions, standard doses, and research on new and existing medications. The Journal includes information on related areas of medical sciences such as advances in developmental pharmacokinetics, developmental neuroscience, metabolism, nutrition, molecular genetics, and more.

Journal of Child and Adolescent Psychopharmacology coverage includes:

New drugs and treatment strategies including the use of psycho-stimulants, selective serotonin reuptake inhibitors, mood stabilizers, and atypical antipsychotics

New developments in the diagnosis and treatment of ADHD, anxiety disorders, schizophrenia, autism spectrum disorders, bipolar disorder, eating disorders, along with other disorders

Reports of common and rare Treatment Emergent Adverse Events (TEAEs) including: hyperprolactinemia, galactorrhea, weight gain/loss, metabolic syndrome, dyslipidemia, switching phenomena, sudden death, and the potential increase of suicide. Outcomes research.

《兒童與青少年精神藥理學雜志》（JCAP）是首屈一指的同行評審期刊，涵蓋使用精神藥物治療該患者群體的臨床方面，包括副作用和相互作用、標準劑量以及對新藥物和現有藥物的研究。該期刊包含有關醫學科學相關領域的信息，例如發育藥代動力學、發育神經科學、代謝、營養、分子遺傳學等方面的進展。

《兒童和青少年精神藥理學雜志》的報道包括：

新藥和治療策略，包括使用精神興奮劑、選擇性血清素再攝取抑制劑、情緒穩定劑和非典型抗精神病藥

多動癥、焦慮癥、精神分裂癥、自閉癥譜系障礙、雙相情感障礙、飲食失調以及其他疾病的診斷和治療的新進展

常見和罕見的治療突發不良事件 (TEAE) 報告，包括：高催乳素血癥、溢乳、體重增加/減少、代謝綜合征、血脂異常、轉換現象、猝死和自殺的潛在增加。結果研究。

Journal Of Child And Adolescent Psychopharmacology創刊于1990年，由Mary Ann Liebert Inc.出版商出版，收稿方向涵蓋醫學 - 精神病學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 12周，或約稿 ，影響因子指數1.5，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。